Fintel reports that on January 7, 2025, Evercore ISI Group upgraded their outlook for Cardinal Health (NYSE:CAH) from In-Line ...

Cardinal Health (CAH – Research Report) received a Buy rating and price target from Evercore ISI analyst Elizabeth Anderson CFA today. The ...

Canandaigua National Bank & Trust Co. lowered its stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 2.8% in the fourth quarter, Holdings Channel reports. The institutional investor ...

Bank of America upgraded shares of Cardinal Health (NYSE:CAH – Free Report) from a neutral rating to a buy rating in a report released on Monday, Marketbeat.com reports. Bank of America currently has ...

The latest trading day saw Cardinal Health (CAH) settling at $119.63, representing a +0.28% change from its previous close.

Fintel reports that on January 6, 2025, B of A Securities upgraded their outlook for Cardinal Health (NYSE:CAH) from Neutral ...

The internet is a treasure trove of fascinating stories, and when it comes to the world of medicine, the tales become even ...

Cardinal Health Inc. CAH is well-poised for growth, given its long-term supply agreements, diversified product portfolio and strong quarterly earnings. However, the possibility of losing a major ...

Market Growth: The global decubitus ulcer treatment products market is expected to grow at a 5.5% CAGR, reaching USD 8.5 ...